Nerio Therapeutics Overview
- Year Founded
-
2019

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.3B
Nerio Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to empower phosphatase drug discovery for immunotherapy. The company offers novel phosphatase modulators, leveraging deep expertise in protein phosphatases, high-throughput screening technologies and structure-guided chemistry approaches, enabling therapeutic intervention with selective, cell-permeable, bioavailable and efficacious small molecule phosphatase modulators for immuno-oncology applications.
Contact Information
Website
www.neriotx.com(Operating Subsidiary)
Corporate Office
- 11099 North Torrey Pines Road
- Suite 280
- La Jolla, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 280
- La Jolla, CA 92037
- United States
Nerio Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 29-Jul-2024 | $1.3B | Completed | Generating Revenue | ||
2. Early Stage VC | 07-Oct-2021 | Completed | Generating Revenue | |||
1. Seed Round | 11-Jul-2020 | $3M | $3M | Completed | Generating Revenue |
Nerio Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed |
Nerio Therapeutics Comparisons
Industry
Financing
Details
Nerio Therapeutics Competitors (66)
One of Nerio Therapeutics’s 66 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
Ambrx | Formerly PE-Backed | San Diego, CA | ||||
Adaptimmune Therapeutics | Formerly VC-backed | Abingdon, United Kingdom | ||||
Ikena Oncology | Formerly VC-backed | Boston, MA | ||||
Biomea Fusion | Formerly VC-backed | Redwood City, CA |
Nerio Therapeutics Patents
Nerio Therapeutics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023216239-A1 | Protein tyrosine phosphatase inhibitors and uses thereof | Pending | 02-Feb-2022 | ||
EP-4472976-A1 | Protein tyrosine phosphatase inhibitors and uses thereof | Pending | 02-Feb-2022 | ||
EP-4472957-A1 | Protein tyrosine phosphatase inhibitors and uses thereof | Pending | 02-Feb-2022 | ||
EP-4472958-A1 | Protein tyrosine phosphatase inhibitors and uses thereof | Pending | 02-Feb-2022 | C07D285/10 |
Nerio Therapeutics Former Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alexandria Venture Investments | Venture Capital | Minority | ||
Avalon Ventures | Venture Capital | Minority | ||
Bregua Corporation | Venture Capital | Minority | ||
Correlation Ventures | Venture Capital | Minority | ||
Viva BioInnovator | Accelerator/Incubator | Minority |
Nerio Therapeutics FAQs
-
When was Nerio Therapeutics founded?
Nerio Therapeutics was founded in 2019.
-
Where is Nerio Therapeutics headquartered?
Nerio Therapeutics is headquartered in La Jolla, CA.
-
What industry is Nerio Therapeutics in?
Nerio Therapeutics’s primary industry is Biotechnology.
-
Is Nerio Therapeutics a private or public company?
Nerio Therapeutics is a Private company.
-
What is the current valuation of Nerio Therapeutics?
The current valuation of Nerio Therapeutics is
. -
What is Nerio Therapeutics’s current revenue?
The current revenue for Nerio Therapeutics is
. -
How much funding has Nerio Therapeutics raised over time?
Nerio Therapeutics has raised $6.5M.
-
Who are Nerio Therapeutics’s investors?
Alexandria Venture Investments, Avalon Ventures, Bregua Corporation, Correlation Ventures, and Viva BioInnovator have invested in Nerio Therapeutics.
-
Who are Nerio Therapeutics’s competitors?
Renova Therapeutics, Ambrx, Adaptimmune Therapeutics, Ikena Oncology, and Biomea Fusion are some of the 66 competitors of Nerio Therapeutics.
-
When was Nerio Therapeutics acquired?
Nerio Therapeutics was acquired on 29-Jul-2024.
-
Who acquired Nerio Therapeutics?
Nerio Therapeutics was acquired by Boehringer Ingelheim.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »